Lloyd Nagasawa
Hematology & Oncology · Mission Viejo, CANPI 1487647335
Payments from drug & device makers
Across 90 payments — averaging $27.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$414
- Puma Biotechnology, Inc.$260
- Pharmacyclics LLC, An Abbvie Company$181
- Novartis$165
- Amgen$155
- Merck$138
- plus $1K from 27 others
What the payments were for
- Food & beverage$2,27393%
- Education$1717%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 12 | $414 |
| Puma Biotechnology, Inc. | 3 | $260 |
| Pharmacyclics LLC, An Abbvie Company | 5 | $181 |
| Novartis | 8 | $165 |
| Amgen | 2 | $155 |
| Merck | 8 | $138 |
| Lilly USA, LLC | 1 | $120 |
| Incyte Corporation | 3 | $108 |
| AbbVie | 5 | $105 |
| Genentech USA, Inc. | 6 | $101 |
| E.r. Squibb & Sons, L.L.C. | 5 | $85 |
| Bayer | 3 | $58 |
| Johnson & Johnson(2 entities) | 3 | $55 |
| Tersera Therapeutics LLC | 2 | $50 |
| Exelixis Inc. | 2 | $50 |
| Pfizer | 3 | $42 |
| Eisai Inc. | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| Verastem, Inc. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| EMD Serono, Inc. | 1 | $22 |
| Sanofi | 1 | $21 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Rigel Pharmaceuticals, Inc. | 1 | $20 |
| Bristol Myers Squibb | 1 | $20 |
| Tolmar Pharmaceuticals, Inc. | 1 | $19 |
| Gilead | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Foundation Medicine, Inc. | 1 | $16 |
| Seagen Inc. | 1 | $15 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $14 |
| Daiichi Sankyo Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,444 in reported general payments places this provider in the 35th percentile of 1,363 hematology & oncology providers in California.
Other hematology & oncology in Mission Viejo
- Alain AlgaziSan Francisco$119.2M
- David BerzLos Angeles$43.3M
- Jonathan GoldmanSanta Monica$35.7M
- Omid HamidSanta Monica$23.7M
- Nicholas McAndrewLos Angeles$22.9M
- Aditya BardiaSanta Monica$22.1M
- Joseph TuscanoSacramento$20.4M
- Zev WainbergSanta Monica$19.3M
- Caitlin CostelloSan Diego$16.9M
- Rana McKaySan Diego$15.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.